Skip to main content
TipRanks
Go Ultimate75% OFF

Health Discovery (HDVY) Ratios

30 Followers

Health Discovery Ratios

HDVY's free cash flow for Q3 2021 was $-435.00K. For the 2021 fiscal year, HDVY's free cash flow was increased by $0.00 and operating cash flow was $-435.00K. See a summary of the company’s cash flow.

Financial ratios
RatiosDec 20Dec 19Dec 18Dec 17
Liquidity Ratios
Current Ratio1.670.830.000.08
Quick Ratio1.670.830.000.08
Cash Ratio1.650.820.000.08
Solvency Ratio-1.360.62-0.46-0.82
Operating Cash Flow Ratio-2.480.79-0.24-0.57
Short-Term Operating Cash Flow Coverage-6.5011.01-0.680.00
Net Current Asset Value$ 375.00K$ -470.51K$ -1.15M$ -700.92K
Leverage Ratios
Debt-to-Assets Ratio0.230.092.660.38
Debt-to-Equity Ratio0.57-0.43-0.41-0.61
Debt-to-Capital Ratio0.36-0.74-0.69-1.59
Long-Term Debt-to-Capital Ratio0.000.000.00-1.59
Financial Leverage Ratio2.49-4.91-0.15-1.61
Debt Service Coverage Ratio-3.370.82-1.17-493.29
Interest Coverage Ratio-174.2043.19-29.77-710.41
Debt to Market Cap0.010.010.250.11
Interest Debt Per Share0.000.000.000.00
Net Debt to EBITDA0.94-1.20-0.80-0.22
Profitability Margins
Gross Profit Margin100.00%100.00%100.00%100.00%
EBIT Margin-74900.00%105.22%-1737.29%-1912.30%
EBITDA Margin-74900.00%115.28%-1144.25%-1327.85%
Operating Profit Margin-174200.00%105.22%-1737.29%-1912.30%
Pretax Profit Margin-75900.00%102.76%-1795.65%-1944.09%
Net Profit Margin-75900.00%102.78%-1795.65%-1944.09%
Continuous Operations Profit Margin-75900.00%0.00%-1795.65%-1944.09%
Net Income Per EBT100.00%100.02%100.00%100.00%
EBT Per EBIT43.57%97.66%103.36%101.66%
Return on Assets (ROA)-81.44%67.50%-520.00%-190.32%
Return on Equity (ROE)-202.40%-331.77%80.05%306.32%
Return on Capital Employed (ROCE)-464.53%-339.64%77.45%932.19%
Return on Invested Capital (ROIC)-296.76%-9.74%131.18%932.19%
Return on Tangible Assets-81.44%67.50%-1187274.63%-2006.95%
Earnings Yield-4.22%9.56%-47.99%-53.60%
Efficiency Ratios
Receivables Turnover0.000.000.000.00
Payables Turnover0.000.000.000.00
Inventory Turnover0.000.000.000.00
Fixed Asset Turnover0.000.000.000.00
Asset Turnover0.000.660.290.10
Working Capital Turnover Ratio-0.02-1.88-0.05-0.15
Cash Conversion Cycle0.000.000.000.00
Days of Sales Outstanding0.000.000.000.00
Days of Inventory Outstanding0.000.000.000.00
Days of Payables Outstanding0.000.000.000.00
Operating Cycle0.000.000.000.00
Cash Flow Ratios
Operating Cash Flow Per Share-0.000.01-0.00-0.00
Free Cash Flow Per Share-0.000.01-0.00-0.00
Dividend Paid and CapEx Coverage Ratio0.000.000.000.00
Capital Expenditure Coverage Ratio0.000.000.000.00
Operating Cash Flow Coverage Ratio-6.5011.01-0.68-1.79
Operating Cash Flow to Sales Ratio-1379.001.45-6.22-6.99
Free Cash Flow Yield-7.67%13.49%-16.62%-19.26%
Valuation Ratios
Price-to-Earnings (P/E) Ratio-23.6810.46-2.08-1.87
Price-to-Sales (P/S) Ratio17972.9810.7537.4236.27
Price-to-Book (P/B) Ratio47.93-34.69-1.67-5.71
Price-to-Free Cash Flow (P/FCF) Ratio-13.037.41-6.02-5.19
Price-to-Operating Cash Flow Ratio-13.037.41-6.02-5.19
Price-to-Earnings Growth (PEG) Ratio0.16-0.040.220.03
Enterprise Value Multiple-23.058.13-4.07-2.95
Enterprise Value17.27M14.23M2.06M1.76M
EV to EBITDA-23.058.13-4.07-2.95
EV to Sales17267.989.3746.6039.19
EV to Free Cash Flow-12.526.46-7.49-5.61
EV to Operating Cash Flow-12.526.46-7.49-5.61
Tangible Book Value Per Share0.00-0.00-0.00-0.00
Shareholders’ Equity Per Share0.00-0.00-0.00-0.00
Tax and Other Ratios
Effective Tax Rate0.001.000.000.00
Revenue Per Share0.000.000.000.00
Net Income Per Share-0.000.00-0.00-0.00
Tax Burden1.001.001.001.00
Interest Burden1.010.981.031.02
Research & Development to Revenue0.000.000.000.00
SG&A to Revenue1743.000.8512.4414.28
Stock-Based Compensation to Revenue268.000.341.961.47
Income Quality1.821.410.350.36

Currency in USD